tiprankstipranks
Eliem Therapeutics (ELYM)
NASDAQ:ELYM
US Market

Eliem Therapeutics (ELYM) Technical Analysis

35 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Eliem Therapeutics’s (ELYM) Moving Averages Convergence Divergence (MACD) indicator is -0.18, suggesting Eliem Therapeutics is a Sell.
Eliem Therapeutics’s (ELYM) 20-Day exponential moving average is 7.18, while Eliem Therapeutics’s (ELYM) share price is $7.3, making it a Buy.
Eliem Therapeutics’s (ELYM) 50-Day exponential moving average is 7.07, while Eliem Therapeutics’s (ELYM) share price is $7.3, making it a Buy.

Eliem Therapeutics (ELYM) Pivot Points

Jul 22, 2024, 10:12 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.28
6.49
6.63
6.84
6.98
7.19
7.33
Fibonacci
6.49
6.62
6.71
6.84
6.97
7.06
7.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Eliem Therapeutics (ELYM) Moving Averages

Jul 22, 2024, 10:12 AM
Period
Simple
Exponential
MA5
6.99Buy
7.04Buy
MA10
6.98Buy
7.04Buy
MA20
7.13Buy
7.18Buy
MA50
7.76Sell
7.07Buy
MA100
5.80Buy
6.17Buy
MA200
4.23Buy
4.82Buy
Eliem Therapeutics’s (ELYM) 10-Day exponential moving average is 7.04, while Eliem Therapeutics’s (ELYM) share price is $7.3, making it a Buy.
Eliem Therapeutics’s (ELYM) 100-Day exponential moving average is 6.17, while Eliem Therapeutics’s (ELYM) share price is $7.3, making it a Buy.
Eliem Therapeutics’s (ELYM) stock price is $7.3 and Eliem Therapeutics’s (ELYM) 50-day simple moving average is 7.76, creating a Sell signal.
Eliem Therapeutics’s (ELYM) stock price is $7.3 and Eliem Therapeutics’s (ELYM) 100-day simple moving average is 5.80, creating a Buy signal.
Eliem Therapeutics’s (ELYM) stock price is $7.3 and Eliem Therapeutics’s (ELYM) 200-day simple moving average is 4.23, creating a Buy signal.

Eliem Therapeutics (ELYM) Technical Indicators

Jul 22, 2024, 10:12 AM
Name
Value
Implied Action
RSI (14)
50.76
Neutral
STOCH (9,6)
39.44
Neutral
STOCHRSI (14)
33.09
Neutral
MACD (12,26)
-0.18
Sell
ADX (14)
13.08
Buy
Williams %R
-33.33
Buy
CCI (14)
-10.04
Neutral
ATR (14)
0.64
-
Ultimate Oscillator
45.30
Neutral
ROC
2.67
Buy
Eliem Therapeutics’s (ELYM) Relative Strength Index (RSI) is 50.76, creating a Neutral signal.
Eliem Therapeutics’s (ELYM) Trend Strength Indicator (ADX) is 13.08, creating a Buy signal.
Eliem Therapeutics’s (ELYM) Commodity Channel Index (CCI) is -10.04, creating a Neutral signal.
Eliem Therapeutics’s (ELYM) Price Rate of Change (ROC) is 2.67, creating a Buy signal.

FAQ

Is ELYM a Buy, Hold, or Sell?
Based on ELYM’s technical indicators, ELYM is a Buy.
    What is ELYM’s RSI (14)?
    ELYM’s RSI (14) is 50.76, which suggests ELYM is a Neutral.
      What is ELYM’s MACD?
      ELYM’s MACD is -0.18, which suggests ELYM is a Sell.
        What is ELYM’s 5-day moving average?
        ELYM’s 5-day moving average is 6.99, which suggests ELYM is a Buy.
          What is ELYM’s 20-day moving average?
          ELYM 20-day moving average is 7.13, which suggests ELYM is a Buy.
            What is ELYM’s 50-day moving average?
            ELYM’s 50-day moving average is 7.76, which suggests ELYM is a Sell.
              What is ELYM’s 200-day moving average?
              ELYM’s 200-day moving average is 4.23, which suggests ELYM is a Buy.
                What is ELYM’s Williams % R (14)?
                ELYM’s Williams % R (14) is -33.33, which suggests ELYM is a Buy.
                  What is ELYM’s CCI (14)?
                  ELYM’s CCI (14) is -10.04, which suggests ELYM is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis